AtriCure, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
AtriCure, Inc. (ATRC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $895.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-19
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-12-31 was $227.00K, a 33.24% decline year-over-year.
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-09-30 was $21.00K, a 75.00% increase year-over-year.
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-06-30 was $212.00K, a 57.04% increase year-over-year.
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2014-03-31 was $1.85M, a 298.92% increase year-over-year.
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $895.00K, a 25.88% increase from fiscal 2024.
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $711.00K, a 76.16% decline from fiscal 2023.
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $2.98M, a 46.42% decline from fiscal 2022.
- AtriCure, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $5.57M, a 79.63% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $895.00K 10-K · filed 2026-02-19 | |||
| 2024-12-31 | $711.00K 10-K · filed 2026-02-19 | |||
| 2023-12-31 | $2.98M 10-K · filed 2026-02-19 | |||
| 2022-12-31 | $5.57M 10-K · filed 2025-02-14 | |||
| 2021-12-31 | $27.32M 10-K · filed 2024-02-16 | |||
| 2020-12-31 | $29.59M 10-K · filed 2023-02-22 | |||
| 2019-12-31 | $1.99M 10-K · filed 2022-02-17 | |||
| 2018-12-31 | $5.34M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $5.12M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $3.55M 10-K · filed 2019-03-01 | |||
| 2015-12-31 | $2.74M 10-K · filed 2018-02-28 | |||
| 2014-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $248.00K derived: sum of 2 quarters · filed 2017-03-08 | $460.00K derived: sum of 3 quarters · filed 2017-03-08 | $2.31M 10-K · filed 2017-03-08 |
| 2014-09-30 | $21.00K 10-Q · filed 2014-10-31 | $233.00K derived: sum of 2 quarters · filed 2014-10-31 | $2.08M 10-Q · filed 2014-10-31 | $2.42M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $212.00K 10-Q · filed 2014-07-30 | $2.06M 10-Q · filed 2014-07-30 | $2.40M derived: sum of 3 quarters · filed 2016-02-29 | $2.42M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.85M 10-Q · filed 2014-04-30 | $2.19M derived: sum of 2 quarters · filed 2016-02-29 | $2.20M derived: sum of 3 quarters · filed 2016-02-29 | $2.34M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $352.00K derived: sum of 2 quarters · filed 2016-02-29 | $487.00K derived: sum of 3 quarters · filed 2016-02-29 | $951.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $12.00K 10-Q · filed 2014-10-31 | $147.00K derived: sum of 2 quarters · filed 2014-10-31 | $611.00K 10-Q · filed 2014-10-31 | $671.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $135.00K 10-Q · filed 2014-07-30 | $599.00K 10-Q · filed 2014-07-30 | $659.00K derived: sum of 3 quarters · filed 2015-03-02 | $693.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $464.00K 10-Q · filed 2014-04-30 | $524.00K derived: sum of 2 quarters · filed 2015-03-02 | $558.00K derived: sum of 3 quarters · filed 2015-03-02 | $1.65M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $94.00K derived: sum of 2 quarters · filed 2015-03-02 | $1.19M derived: sum of 3 quarters · filed 2015-03-02 | $1.34M 10-K · filed 2015-03-02 |
| 2012-09-30 | $34.00K 10-Q · filed 2013-11-01 | $1.13M derived: sum of 2 quarters · filed 2013-11-01 | $1.28M 10-Q · filed 2013-11-01 | $1.77M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | $1.09M 10-Q · filed 2013-08-02 | $1.24M 10-Q · filed 2013-08-02 | $1.74M derived: sum of 3 quarters · filed 2014-03-11 | $1.75M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | $151.00K 10-Q · filed 2013-05-03 | $643.00K derived: sum of 2 quarters · filed 2014-03-11 | $656.00K derived: sum of 3 quarters · filed 2014-03-11 | $1.96M derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | $492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $505.00K derived: sum of 2 quarters · filed 2014-03-11 | $1.81M derived: sum of 3 quarters · filed 2014-03-11 | $3.40M 10-K · filed 2014-03-11 |
| 2011-09-30 | $13.00K 10-Q · filed 2012-11-02 | $1.32M derived: sum of 2 quarters · filed 2012-11-02 | $2.91M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $1.31M 10-Q · filed 2012-08-03 | $2.90M 10-Q · filed 2012-08-03 | ||
| 2010-12-31 | $312.00K 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |